Literature DB >> 7738684

15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine.

N Roos1, S Mahé, R Benamouzig, H Sick, J Rautureau, D Tomé.   

Abstract

To evaluate true ileal digestibility of bovine immunoglobulins, seven healthy human adults ingested a 15N-labeled preparation of an immunoglobulin concentrate. After fasting overnight, subjects drank 400 mL of immunoglobulin concentrate (77 mmol), and ileal effluents were collected for 8 h at 20-min intervals using a naso-intestinal intubation technique. In addition to osmolality and pH, the concentrations of exogenous and endogenous nitrogen and ions (Na+, K+, Cl-, Ca2+, Mg2+) in the effluents were measured. Bovine immunoglobulin concentrations (IgG, IgM, IgA) were estimated by a radial immunodiffusion technique. The mean flow rate of the liquid phase was 22.3 +/- 6.1 mL/20 min and did not vary significantly during the collection period. No change was observed for osmolality, pH or Na+, K+ and Cl- concentrations. Two hours after meal ingestion, Ca2+ and Mg2+ concentrations increased significantly (P < 0.05). The recoveries of nitrogen of ingested IgG and IgM still immunologically active were 19 +/- 3% and 19 +/- 4%, respectively. No IgA was detected in the ileum. Mean digestibility of the exogenous nitrogen fraction was 79 +/- 3%. In comparison to literature data, which show that other milk proteins have ileal digestibilities of > 90%, our results demonstrate a lower ileal digestibility of bovine immunoglobulins in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738684     DOI: 10.1093/jn/125.5.1238

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  26 in total

Review 1.  Passive immunity against human pathogens using bovine antibodies.

Authors:  C Weiner; Q Pan; M Hurtig; T Borén; E Bostwick; L Hammarström
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Construction and characterization of a goat mammary gland cDNA library.

Authors:  Xue Feng Han; Jun Luo; Ning Wu; Kanyand Matand; Bao Jin Yang; Hui Juan Wu; Li Juan Zhang; Hai Bin Wang
Journal:  Mol Biotechnol       Date:  2007-11-30       Impact factor: 2.695

Review 3.  Bioactive peptides and proteins from foods: indication for health effects.

Authors:  Niels Peter Möller; Katharina Elisabeth Scholz-Ahrens; Nils Roos; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2008-05-27       Impact factor: 5.614

4.  Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.

Authors:  M Warny; A Fatimi; E F Bostwick; D C Laine; F Lebel; J T LaMont; C Pothoulakis; C P Kelly
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

5.  Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells.

Authors:  E J Israel; S Taylor; Z Wu; E Mizoguchi; R S Blumberg; A Bhan; N E Simister
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

6.  Do Orally Administered Immunoglobulin-Based Agents Represent the Future of IBD Therapeutics?

Authors:  Jason M Shapiro; Basavaraj Kerur
Journal:  Dig Dis Sci       Date:  2015-07-17       Impact factor: 3.199

7.  Structural features of bovine colostral immunoglobulin that confer proteolytic stability in a simulated intestinal fluid.

Authors:  Randall E Burton; Skaison Kim; Rutvij Patel; Deborah S Hartman; Daniel E Tracey; Barbara S Fox
Journal:  J Biol Chem       Date:  2020-07-14       Impact factor: 5.157

8.  Survival of Immunoglobulins from Human Milk to Preterm Infant Gastric Samples at 1, 2, and 3 h Postprandial.

Authors:  Veronique Demers-Mathieu; Mark A Underwood; Robert L Beverly; David C Dallas
Journal:  Neonatology       Date:  2018-06-25       Impact factor: 4.035

9.  Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.

Authors:  C P Kelly; S Chetham; S Keates; E F Bostwick; A M Roush; I Castagliuolo; J T LaMont; C Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 10.  Bovine colostrum supplementation and exercise performance: potential mechanisms.

Authors:  Cecilia M Shing; Denise C Hunter; Lesley M Stevenson
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.